XML 83 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-In Capital
Cumulative Distributions
Accumulated Income (Deficit)
Accumulated Other Comprehensive (Loss) Income
Non- controlling Interests
Beginning Balance (in shares) at Dec. 31, 2018     174,278,341          
Beginning Balance at Dec. 31, 2018 $ 1,344,286 $ 1,112,083 $ 174 $ 1,556,770 $ (570,977) $ 128,525 $ (2,409) $ 232,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Deferred equity compensation (in shares)     7,336          
Deferred equity compensation 75 75   75        
Cash distributions to common stockholders (21,803) (21,803)     (21,803)      
Issuance of shares for distribution reinvestment plan (in shares)     695,872          
Issuance of shares for distribution reinvestment plan 0   $ 1 6,672 (6,673)      
Reclass of common stock subject to redemption (6,673) (6,673)   (6,673)        
Distributions to noncontrolling interest (4,585)             (4,585)
Distributions to noncontrolling interests subject to redemption (13)             (13)
Offering costs (9) (9)   (9)        
Net income 6,530 5,333       5,333   1,197
Other comprehensive loss (8,137) (6,729)         (6,729) (1,408)
Ending Balance(in shares) at Mar. 31, 2019     174,981,549          
Ending Balance at Mar. 31, 2019 1,309,671 1,082,277 $ 175 1,556,835 (599,453) 133,858 (9,138) 227,394
Beginning Balance (in shares) at Dec. 31, 2018     174,278,341          
Beginning Balance at Dec. 31, 2018 $ 1,344,286 1,112,083 $ 174 1,556,770 (570,977) 128,525 (2,409) 232,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of stock dividend for noncontrolling interest               1,861
Distributions to noncontrolling interest               (19,716)
Net income               3,749
Other comprehensive loss               (3,054)
Ending Balance(in shares) at Dec. 31, 2019 227,853,720   227,853,720          
Ending Balance at Dec. 31, 2019 $ 1,721,517 1,476,477 $ 228 2,060,604 (715,792) 153,312 (21,875) 245,040
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Gross proceeds from issuance of common stock (in shares)     433,328          
Gross proceeds from issuance of common stock 4,141 4,141   4,141        
Deferred equity compensation (in shares)     17,836          
Deferred equity compensation 984 984   984        
Cash distributions to common stockholders (23,627) (23,627)     (23,627)      
Issuance of shares for distribution reinvestment plan (in shares)     1,297,656          
Issuance of shares for distribution reinvestment plan 4,155 4,155 $ 1 12,116 (7,962)      
Repurchase of common stock (in shares)     (548,312)          
Repurchase of common stock (5,110) (5,110)   (5,110)        
Reclass of common stock subject to redemption (85,180) (85,180)   (85,180)        
Issuance of stock dividend for noncontrolling interest 802             802
Issuance of stock dividends (in shares)     617,327          
Issuance of stock dividends 19 19 $ 1 5,766 (5,748)      
Distributions to noncontrolling interest (5,069)             (5,069)
Distributions to noncontrolling interests subject to redemption (11)             (11)
Offering costs (604) (604)   (604)        
Net income 848 737       737   111
Other comprehensive loss $ (30,826) (27,118)         (27,118) (3,708)
Ending Balance(in shares) at Mar. 31, 2020 229,671,555   229,671,555          
Ending Balance at Mar. 31, 2020 $ 1,582,039 $ 1,344,874 $ 230 $ 1,992,717 $ (753,129) $ 154,049 $ (48,993) $ 237,165